Latest Headlines

Latest Headlines

Merck New Jersey plant to close in October

The company has sent notices to 113 employees at the Kenilworth, NJ, plant. It will move what manufacturing remains to a plant in Cleveland, TN.

More Merck manufacturing cuts on the way

CEOs have been offering up cuts to manufacturing operations as one antidote to sick balance sheets during the most recent round of earnings updates and Merck is among those whittling away.

Merck whacking jobs at Canada plant it expanded last year

A report, citing  La Presse, says Merck is cutting a quarter of its workforce at a plant in Pointe Claire, Canada.

Merck plots HQ move to former Schering site

Merck ($MRK) is saying "so long" to Whitehouse Station, NJ. The drugmaker says it will move its global headquarters to nearby Summit, NJ, after 20 years there. The Summit site already houses 1,800 people working in several different Merck groups, and moving the HQ there will save space and money.

Brazil seizes 3 lots of counterfeit Schering-Plough drugs

Authorities in Brazil have seized counterfeit versions of two Schering-Plough drugs that are popular among bodybuilders.

Pharma's Top 5 Golden Handshakes of the Last 5 Years

It's an all-too-familiar frustration for pharma shareholders. On the heels of declining revenues and mismanagement, a CEO departs, and then comes the golden handshake.

Merck tracks positive results, bleeding risk in second big vorapaxar study

Merck says that vorapaxar, its troubled blood thinner once considered the jewel in Schering-Plough's crown when the pharma giant bought it for $41 billion, hit its primary efficacy endpoint in a

Feds subpoena Merck in marketing probe

Merck has stumbled into one of the hidden traps of megamergers. The Department of Justice is probing the marketing of three drugs inherited from Schering-Plough, Merck disclosed to the SEC in a

S-P sales reps win another OT round

Chalk up another victory for sales reps in their fight for overtime pay. A U.S. judge has decided that Schering-Plough sales people don't qualify for the administrative exemption under U.S. labor

Merck to re-invest in scaled-back Irish plant

This is what you call taking away with one hand while giving with the other. Merck says it's planning to invest €29 million ($41.8 million) at its plant in Cork, Ireland, and create 70 jobs